| Role of cytokines in inflammatory bowel disease F Sanchez-Muñoz, A Dominguez-Lopez, JK Yamamoto-Furusho World journal of gastroenterology: WJG 14 (27), 4280, 2008 | 848 | 2008 |
| Rheumatic manifestations of inflammatory bowel disease TS Rodríguez-Reyna, C Martínez-Reyes, JK Yamamoto-Furusho World journal of gastroenterology: WJG 15 (44), 5517, 2009 | 157 | 2009 |
| IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010-Inflammatory bowel disease task force meeting DC Baumgart, CN Bernstein, Z Abbas, JF Colombel, AS Day, G D'Haens, ... Inflammatory bowel diseases 17 (2), 639-644, 2011 | 139 | 2011 |
| Immunoregulatory pathways involved in inflammatory bowel disease G Fonseca-Camarillo, JK Yamamoto-Furusho Inflammatory bowel diseases 21 (9), 2188-2193, 2015 | 133 | 2015 |
| Tumor necrosis factor-α promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE) J Zuniga, G Vargas-Alarcón, G Hernández-Pacheco, C Portal-Celhay, ... Genes & Immunity 2 (7), 363-366, 2001 | 119 | 2001 |
| Association of HLA-DR4 (DRB1* 0404) with human papillomavirus infection in patients with focal epithelial hyperplasia C García-Corona, E Vega-Memije, A Mosqueda-Taylor, ... Archives of dermatology 140 (10), 1227-1231, 2004 | 116 | 2004 |
| Innate immunity in inflammatory bowel disease JK Yamamoto-Furusho, DK Podolsky World journal of gastroenterology: WJG 13 (42), 5577, 2007 | 109 | 2007 |
| Centaurin β1 down-regulates nucleotide-binding oligomerization domains 1-and 2-dependent NF-κB activation JK Yamamoto-Furusho, N Barnich, R Xavier, T Hisamatsu, DK Podolsky Journal of biological chemistry 281 (47), 36060-36070, 2006 | 101 | 2006 |
| Basic and clinical aspects of osteoporosis in inflammatory bowel disease L Rodriguez-Bores, J Barahona-Garrido, JK Yamamoto-Furusho World Journal of Gastroenterology: WJG 13 (46), 6156, 2007 | 98 | 2007 |
| Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study G Fonseca-Camarillo, J Furuzawa-Carballeda, J Granados, ... Clinical & Experimental Immunology 177 (1), 64-75, 2014 | 93 | 2014 |
| Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006) JK Yamamoto-Furusho Journal of clinical gastroenterology 43 (3), 221-224, 2009 | 90 | 2009 |
| Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis F Sánchez-Muñoz, G Fonseca-Camarillo, MA Villeda-Ramírez, ... BMC gastroenterology 11, 1-9, 2011 | 88 | 2011 |
| Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease G Fonseca-Camarillo, J Furuzawa-Carballeda, JK Yamamoto-Furusho Cytokine 75 (2), 389-402, 2015 | 85 | 2015 |
| Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells E Flores-Hernández, DM Velázquez, MC Castañeda-Patlán, ... Cellular signalling 72, 109636, 2020 | 79 | 2020 |
| Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis JK Yamamoto-Furusho, LF Uscanga, G Vargas-Alarcón, JA Ruiz-Morales, ... Human immunology 64 (1), 119-123, 2003 | 79 | 2003 |
| Further evidence of the role of HLA-DR4 in the genetic susceptibility to actinic prurigo T Hojyo-Tomoka, J Granados, G Vargas-Alarcón, JK Yamamoto-Furusho, ... Journal of the American Academy of Dermatology 36 (6), 935-937, 1997 | 77 | 1997 |
| Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course JK Yamamoto-Furusho, E Torijano-Carrera Digestion 82 (1), 18-23, 1954 | 74 | 1954 |
| Novel genetic markers in inflammatory bowel disease L Rodríguez-Bores, GC Fonseca, MA Villeda, JK Yamamoto-Furusho World journal of gastroenterology: WJG 13 (42), 5560, 2007 | 72 | 2007 |
| Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation JK Yamamoto-Furusho, F Bosques-Padilla, J De-Paula, MT Galiano, ... Revista de Gastroenterología de México 82 (1), 46-84, 2017 | 71 | 2017 |
| Peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression is downregulated in patients with active ulcerative colitis JK Yamamoto-Furusho, A Peñaloza-Coronel, F Sánchez-Muñoz, ... Inflammatory bowel diseases 17 (2), 680-681, 2011 | 68 | 2011 |
